List of insiders holdings for Altimmune Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | EVNIN LUKE GALAKATOS NICHOLAS HENNER DENNIS STEINMETZ MICHAEL GADICKE ANSBERT WHEELER KURT SIMON NICHOLAS J III 10% Owner | 2010-11-05 15:59:59 | 0 6,347,614 | 6,347,614 | Form 4 |
| 2 | PRESCOTT GROUP CAPITAL MANAGEMENT L.L.C. FROHLICH PHIL 10% Owner | 2017-02-10 16:07:09 | 3,262,422 0 | 3,262,422 | Form 13G |
| 3 | VELOCITY PHARMACEUTICAL HOLDINGS LLC 10% Owner | 2021-02-16 16:23:13 | 1,938,335 0 | 1,938,335 | Form 13G |
| 4 | VELOCITY PHARMACEUTICAL HOLDINGS LLC Collier David J Watson James F Velocity Pharma Management LLC 10% Owner | 2021-02-16 16:23:13 | 1,938,335 0 | 1,938,335 | Form 13G |
| 5 | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Venrock Healthcare Capital Partners II L.P. VHCP Co-Investment Holdings II LLC VHCP Management II LLC Koh Bong Y Shah Nimish P 10% Owner | 2022-02-14 16:20:46 | 1,760,870 0 | 1,760,870 | Form 13G |
| 6 | Truffle Capital S.A.S. 10% Owner | 2018-02-15 16:49:37 | 0 1,537,442 | 1,537,442 | Form 4 |
| 7 | RICHMAN ERIC I Director | 2016-11-23 16:46:05 | 898,055 10,000 | 908,055 | Form 4 |
| 8 | KINLEY MATTHEW P Former President & Treasurer | 2007-08-16 19:40:58 | 611,980 0 | 611,980 | Form 4/A |
| 9 | SCHAFFER DERACE L Director | 2018-01-02 17:09:50 | 589,453 12,393 | 601,846 | Form 4 |
| 10 | Hodges Philip Redmont VAXN Capital Holdings LLC Director | 2017-10-19 17:21:06 | 583,691 0 | 583,691 | Form 13D |
| 11 | Hodges Philip Redmont VAXN Capital Holdings LLC Redmont Venture Partners Inc. Paradigm Venture Partners L.P. Director | 2017-10-19 17:21:06 | 583,691 0 | 583,691 | Form 13D |
| 12 | Garg Vipin K Director | 2026-02-02 16:15:29 | 451,294 0 | 451,294 | Form 4 |
| 13 | WRIGHT DAVID P President and CEO | 2009-12-14 12:49:09 | 399,500 0 | 399,500 | Form 4 |
| 14 | Enright William President and CEO | 2018-05-29 18:17:36 | 365,839 0 | 365,839 | Form 4 |
| 15 | HEALTHCARE VENTURES VII LP HealthCare Partners VII L.P. CAVANAUGH JAMES H LITTLECHILD JOHN W WERNER HAROLD R LAWLOR AUGUSTINE Mirabelli Christopher AGUIAR ERIC 10% Owner | 2011-10-05 16:45:07 | 358,814 0 | 358,814 | Form 13G |
| 16 | HEALTHCARE VENTURES VII LP LAWLOR AUGUSTINE LITTLECHILD JOHN W Mirabelli Christopher WERNER HAROLD R CAVANAUGH JAMES H HealthCare Partners VII L.P. 10% Owner | 2011-10-05 16:45:07 | 358,814 0 | 358,814 | Form 13G |
| 17 | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 2019-02-05 16:05:59 | 309,216 0 | 309,216 | Form 13G |
| 18 | St Peter Steven Director | 2017-01-05 16:31:04 | 205,004 0 | 205,004 | Form 4 |
| 19 | Runge Jeffrey W. Director | 2017-01-24 16:30:35 | 197,700 0 | 197,700 | Form 4 |
| 20 | Cook Francesca M SVP, Policy & Gov't Affairs | 2014-12-10 20:59:59 | 171,582 0 | 171,582 | Form 4 |
| 21 | MORGES WAYNE SVP, Reg. Affairs & Quality | 2014-12-10 21:01:44 | 167,096 0 | 167,096 | Form 4 |
| 22 | Price Kevin President - PharmAthene UK,Ltd | 2009-02-10 17:07:34 | 166,900 0 | 166,900 | Form 4 |
| 23 | MACNEILL PHILIP VP, CFO, Treasurer, Secretary | 2016-12-22 16:15:33 | 166,658 0 | 166,658 | Form 4 |
| 24 | MILLENCO L.L.C. MILLENNIUM MANAGEMENT L.L.C. ENGLANDER ISRAEL A 10% Owner | 2024-10-16 16:21:16 | 144,153 0 | 144,153 | Form 13G |
| 25 | Arbet-Engels Christophe Chief Medical Officer | 2026-10-05 16:10:15 | 137,321 0 | 137,321 | Form 4 |
| 26 | CZEREPAK ELIZABETH CFO and EVP Corp. Development | 2017-09-26 18:36:33 | 125,000 0 | 125,000 | Form 4 |
| 27 | Jones Jeffrey Michael COO | 2015-03-27 16:58:44 | 123,680 0 | 123,680 | Form 3 |
| 28 | MENZIUSO RICHARD THOMAS Principal Accounting Officer | 2026-10-02 16:17:53 | 120,780 0 | 120,780 | Form 4 |
| 29 | Roberts M Scot Chief Scientific Officer | 2026-08-03 16:05:19 | 113,699 0 | 113,699 | Form 4 |
| 30 | FUERST THOMAS RICHARD EVP, Chief Scientific Officer | 2011-12-05 20:21:44 | 104,545 0 | 104,545 | Form 4 |
| 31 | WEAVER GREGORY L Chief Financial Officer | 2026-10-05 16:05:26 | 93,352 0 | 93,352 | Form 4 |
| 32 | Richardson Linda M Chief Commercial Officer | 2026-09-17 16:05:29 | 89,174 0 | 89,174 | Form 4 |
| 33 | Harris Matthew Scott Chief Medical Officer | 2025-08-04 16:05:50 | 16,087 67,787 | 83,874 | Form 4 |
| 34 | Riddle Valerie D SVP, Medical Director | 2011-06-01 21:12:43 | 79,380 0 | 79,380 | Form 4 |
| 35 | CHANG LINDA L SVP, CFO & Secretary | 2015-01-09 19:00:24 | 75,400 0 | 75,400 | Form 4 |
| 36 | Reinhart Charles A. III SVP, Chief Financial Officer | 2010-12-10 17:09:44 | 75,000 0 | 75,000 | Form 4 |
| 37 | Eisenstadt Richard I Chief Financial Officer | 2024-02-01 18:00:16 | 72,837 0 | 72,837 | Form 4 |
| 38 | Jordt Raymond M Chief Business Officer | 2026-02-02 16:10:06 | 70,107 0 | 70,107 | Form 4 |
| 39 | Karp Jordan P SVP, General Counsel | 2012-12-05 19:24:25 | 65,000 0 | 65,000 | Form 4 |
| 40 | Durso Jerome Benedict President and CEO | 2026-08-13 16:05:06 | 62,500 0 | 62,500 | Form 4 |
| 41 | Drutz David Director | 2024-08-20 18:05:08 | 4,350 55,524 | 59,874 | Form 4 |
| 42 | Lawver Teri L Director | 2026-05-01 16:23:16 | 48,800 0 | 48,800 | Form 4 |
| 43 | Sohn Catherine A. Director | 2026-05-01 16:20:49 | 48,800 0 | 48,800 | Form 4 |
| 44 | Jorkasky Diane Director | 2026-05-01 16:18:40 | 48,800 0 | 48,800 | Form 4 |
| 45 | SAYARE MITCHEL Director | 2026-05-01 16:05:59 | 48,800 0 | 48,800 | Form 4 |
| 46 | GILL JOHN Director | 2026-05-01 16:08:42 | 48,800 0 | 48,800 | Form 4 |
| 47 | Hodges Philip Director | 2026-05-01 16:11:03 | 48,800 0 | 48,800 | Form 4 |
| 48 | Pisano Wayne Director | 2026-05-01 16:13:30 | 48,800 0 | 48,800 | Form 4 |
| 49 | Schafer Klaus Director | 2026-05-01 16:16:09 | 48,800 0 | 48,800 | Form 4 |
| 50 | Camut Christopher C VP, Gov't Contracts | 2010-01-29 14:55:24 | 46,777 0 | 46,777 | Form 4 |
| 51 | Schellhammer Wayne A Former Director Director | 2007-08-07 20:05:08 | 22,500 0 | 22,500 | Form 4 |
| 52 | Berger Edward B Former Director Director | 2007-08-09 17:08:52 | 22,500 0 | 22,500 | Form 4 |
| 53 | Tasker Sybil Chief Medical Officer | 2019-06-19 16:01:29 | 20,000 0 | 20,000 | Form 4 |
| 54 | PAPPAJOHN JOHN Director | 2011-06-27 19:47:22 | 20,000 0 | 20,000 | Form 4 |
| 55 | Brown William Michael Chief Financial Officer | 2021-08-06 19:01:07 | 17,721 0 | 17,721 | Form 4 |
| 56 | MARKISON BRIAN A Director | 2015-01-05 21:30:49 | 12,241 0 | 12,241 | Form 4 |
| 57 | Shutterly Andrew Acting Chief Financial Officer | 2024-08-01 17:47:59 | 11,372 0 | 11,372 | Form 4 |
| 58 | Fusco Joan SVP, Operations | 2010-05-17 17:34:16 | 0 10,000 | 10,000 | Form 4/A |
| 59 | McCleary Joel Director | 2015-01-05 21:28:30 | 5,061 0 | 5,061 | Form 4 |
| 60 | MPM BIOVENTURES III LLC MPM BIOVENTURES III PARALLEL FUND L.P. MPM BIOVENTURES III GMBH & CO. Beteiligungs KG MPM BIOVENTURES III L.P. MPM BIOVENTURES III GP L.P. MPM BIOVENTURES III-QP L.P. MPM Asset Management Investors 2004 BVIII LLC 10% Owner | 2016-03-29 20:53:06 | 0 0 | 0 | Form 13D |